| 249553 |
Recombinant |
GlaxoSmithKline |
|
| Abraxane |
Solvent-free nanoparticle albumin-bound chemotherapeutic |
American Pharmaceutical Partners |
II |
| ABX-MAI |
MoAB anti MUC18 |
Abgenix |
I |
| Alkylade (0-6-benzylguanine) |
AGT inhibitor |
Access Oncology, Pacific Pharmaceuticals |
II |
| Allovectin-7 |
Gene therapy |
Vical |
II |
| Alvac-gp100 vaccine |
Vaccine |
Aventis |
I/II |
| Ampligen |
RNA |
Hemispherx Biopharma |
II |
| BAY 43-9006 (sorafenib) |
MKI VEGFR-2, VEGFR-3, PDGFR-B, RAF, Kit, FLT-3, RET |
Bayer Pharmaceuticals Onyx Pharmaceuticals |
II |
| BEC2 (mitumomab) |
Anti-idiotype monoclonal antibody |
ImClone Systems |
II |
| BMS248479 |
Vaccine |
BMS |
III |
| Canvaxin |
Vaccine |
CancerVax |
III |
| Ceplene (histamine dihydrochloride) |
Synthetic nucleoside analog |
Maxim Pharmaceuticals |
III |
| Dacogen (decitabine) |
DNA methlytransferase inhibitor |
MGI |
I |
| ELL-12 (ether lipid) |
Ether-based antineoplastic |
Elan |
II |
| Endostatin (human endostatin) |
Angiogenesis inhibitor |
EntreMed |
II |
| Genasense (oblimersen) |
Antisense |
Genta and Aventis |
Submitted |
| GM2-KLH and QS21 |
Vaccine |
Biomira |
III |
| GMK |
Vaccine |
Progenics Pharmaceuticals |
III |
| ILX-651 |
|
Ilex |
II |
| IMC-GP75 |
Vaccine |
Imclone |
I |
| Javelin |
Vaccine |
Mojave Therapeutics |
I |
| KW-2871(ecromeximab) |
MoAb |
BioWatac |
II |
| MDX-010 |
Anti-CTLA-4 antibody |
Medarex |
II |
| Melacine |
vaccine |
Corixa Corp. |
III |
| MVAX |
Vaccine |
Ava Tech |
I |
| Oncophage (HSPPC-96) |
Heat shock protein vaccine |
Antigenics |
III |
| Pegasys (peginterferon alfa-2a) |
Interferon |
Roche |
II |
| Peg-intron (peginterferon alfa-2b) |
Pegylated interferon alfa-2b |
Schering-Plough |
III |
| PI-88 |
Anti-VEGF |
Progren Industry |
II |
| Promune (CpG 7909) |
TLP9 agonist |
Pfizer |
II |
| Revimid |
Immunomodulator |
Celgene |
III |
| RAAV Vaccine |
Vaccine |
MediGene AG Aventis |
I |
| RF-GP100 - Therion Biologics |
Recombinant fowlpox vaccine |
Therion Biologics |
II |
| Rf-gp100 - Therion Biologics, NCI |
Recombinant fowlpox vaccine |
Therion Biologics, NCI |
III |
| S-17/19 |
Antibody-prodrug combination |
Seattle Genetics |
Preclinical |
| Solaraze |
Diclofenac gel |
Skye Pharma |
FDA submission |
| Taxoprexin (docosahexaenoic acid-paclitaxel) |
Taxane |
Protarga |
III |
| Uvidem |
Vaccine |
Sanofi-Aventis |
II |
Patient Home
Meeting Calendar
